BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5125834)

  • 1. [Coronary arteries and myocardial perfusion in experimental acute vascular occlusion. Influence of pharmacological coronary dilatation].
    Hahn N; Felix R; Draznin N; Mayer R; Düx A; Sporbeck G
    Med Welt; 1971 Oct; 44():1738-40. PubMed ID: 5125834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-support of active therapy for rehabilitation in coronary insufficiency].
    Schleusing G
    Z Gesamte Inn Med; 1970 Aug; 25(15):680-5. PubMed ID: 5005761
    [No Abstract]   [Full Text] [Related]  

  • 3. [Survival rate after acute experimental coronary occlusion as related to the spontaneous collateral vessels in hearts].
    Meesmann W; Schulz FW; Schley G; Adolphsen P
    Z Gesamte Exp Med Einschl Exp Chir; 1970; 153(3):246-64. PubMed ID: 5526834
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimental study comparing the acute occlusion of the anterior descending and the left circumflex coronary arteries.
    Pifarré R; Hufnagel CA
    J Thorac Cardiovasc Surg; 1966 Jun; 51(6):761-6. PubMed ID: 5944099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of caffeine alone and in combination with strophanthin on collateral coronary circulation during acute occlusion of the coronary artery].
    Sapozhkov AC
    Biull Eksp Biol Med; 1970 Aug; 70(8):64-6. PubMed ID: 5492877
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ildamen in stenocardias].
    Z Allgemeinmed; 1971 Jun; 47(17):921-5. PubMed ID: 4397205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of pressure-induced cardiac hypertrophy on mortality following experimental coronary occlusion and on development of collateral coronary vessels].
    Bishoff KO; Meesmann W; Stephan K; Wild U
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():324-7. PubMed ID: 4281219
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of oxyfedrine in the treatment of coronary disease. Apropos of 100 cases].
    Hiltenbrandt C; Gerard A; Maecker P; Desruelles J
    Lille Med; 1972 Oct; 17(9):1288-93. PubMed ID: 4657642
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with oxyphedrine in the treatment of ischemic cardiopathy].
    Almeida SP
    Rev Bras Med; 1971 Dec; 28(12):644-52. PubMed ID: 5145755
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic studies of a coronary vasodilator, Ildamen].
    Saito T; Hirano T; Fujino A
    Masui; 1971 Feb; 20(2):122-6. PubMed ID: 5101998
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic arteriogenesis has arrived.
    Schaper W
    Circulation; 2001 Oct; 104(17):1994-5. PubMed ID: 11673333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of the microcirculation in the experimental treatment of coronary insufficiency with verapamil and the clinical use of verapamil in revascularization of the heart].
    Svecov IM; Derzavez LC; Krutik IG; Culkova IP; Dobrochotov GS
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1328+. PubMed ID: 5536557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies on the blood pressure in acute corronary arterial occlusion and its relation to the dynamic parameters of the coronary circulation].
    Schuldt HH; Seifert S
    Z Kreislaufforsch; 1968 Aug; 57(8):720-9. PubMed ID: 5678701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic and clinical studies of the coronary therapeutic agent oxyfedrin].
    Krosch H; Rikirsch P; Schäbitz J; Teichmann W
    Z Arztl Fortbild (Jena); 1972 Jun; 66(11):557-62. PubMed ID: 5072115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxyfedrine--an anti-angor drug with beta-stimulating characteristics. Bibliographic data and clinical experimentation].
    Carlier J
    Rev Med Liege; 1970 Dec; 25(24):797-803. PubMed ID: 5502748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of the coronary effect of oxyfedrin].
    Bayer BL; Mentz P; Förster W
    Acta Biol Med Ger; 1972; 28(6):1085-7. PubMed ID: 4674026
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the prognosis and rehabilitation of the myocardial infarction from the viewpoint of collateral circulation.
    Suzuki N
    Jpn Circ J; 1967 Nov; 31(11):1588-93. PubMed ID: 5630878
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of glutamic and aspartic acid on collateral circulation and oxygen tension in the myocardium].
    Sapozhkov AV
    Patol Fiziol Eksp Ter; 1968; 12(5):20-3. PubMed ID: 5747630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.